These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 1858591)
41. Complete response of a recurrent advanced urachal carcinoma treated by S-1/cisplatin combination chemotherapy. Kojima Y; Yamada Y; Kamisawa H; Sasaki S; Hayashi Y; Kohri K Int J Urol; 2006 Aug; 13(8):1123-5. PubMed ID: 16903943 [TBL] [Abstract][Full Text] [Related]
42. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy. George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577 [TBL] [Abstract][Full Text] [Related]
43. [Bladder cancer with skin metastasis: a case report]. Segawa N; Kotake Y; Hamada S; Takahara K; Azuma H; Katsuoka Y; Tsuji M Hinyokika Kiyo; 2006 Sep; 52(9):711-4. PubMed ID: 17040057 [TBL] [Abstract][Full Text] [Related]
44. [Treatment using concomitant radiochemotherapy of N+ M0 stage urothelial tumors of the bladder]. Benoit G; Di Palma M; Blanchet P; Lecouturier S; Yataghene Y; Decroix Y; Misset JL; Jardin A Prog Urol; 1995 Sep; 5(4):522-8. PubMed ID: 7581502 [TBL] [Abstract][Full Text] [Related]
45. [The role of M-VAC polychemotherapy in the treatment of advanced urothelial carcinoma of the bladder]. Stöckle M; Meyenburg W; Wellek S; Voges G; Gertenbach U; Thüroff JW; Huber C; Hohenfellner R Ann Urol (Paris); 1993; 27(1):51-7. PubMed ID: 7682388 [TBL] [Abstract][Full Text] [Related]
46. [Successful inhibition of bladder tumor recurrence by oral administration of UFT]. Nakamoto T; Igawa M; Usui T Gan To Kagaku Ryoho; 1994 Apr; 21(5):697-9. PubMed ID: 8154896 [No Abstract] [Full Text] [Related]
47. [Complete response of a massive hepatocellular carcinoma with lung metastasis to UFT (DPD inhibitory fluoroprymidines: DIF)]. Haseme E; Shohkei O; Ohnishi Y; Kikuchi K Gan To Kagaku Ryoho; 2001 Feb; 28(2):247-51. PubMed ID: 11242656 [TBL] [Abstract][Full Text] [Related]
48. Impact of methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy in patients with lymph node metastases from transitional cell carcinoma of the lower urinary tract. Koch MO; Coussens D Semin Urol; 1993 Feb; 11(1):14-9. PubMed ID: 8465122 [No Abstract] [Full Text] [Related]
49. [A randomized controlled study comparing uracil-tegafur (UFT)+tamoxifen (UFT+TAM therapy) with cyclophosphamide+adriamycin+5-fluorouracil (CAF therapy) for women with stage I , II, or IIIa breast cancer with four or more involved nodes in the adjuvant setting]. Inaji H; Sakai K; Oka T; Ozawa K; Saito Y; Senoo T; Taguchi T; Terasawa T; Nakao K; Mori T; Koyama H; Oshima A Gan To Kagaku Ryoho; 2006 Oct; 33(10):1423-9. PubMed ID: 17033231 [TBL] [Abstract][Full Text] [Related]
50. [A phase II study of UFT in non-small cell lung cancer]. Shimizu E; Kimura K; Sone S; Inoue I; Nakamura Y; Noda Y; Hojo F; Yagi M; Nakanishi S; Yamasaki K Gan To Kagaku Ryoho; 1986 Oct; 13(10):2970-3. PubMed ID: 3021068 [TBL] [Abstract][Full Text] [Related]
51. [Conservative treatment with chemotherapy and radiotherapy in bladder cancer invading the muscle: preliminary results of a prospective study]. Zapatero A; Pinar B; Arellano R; López M; Marín A; Jiménez U; Pérez Torrubia A Arch Esp Urol; 1997 Jun; 50(5):448-54; discussion 454-6. PubMed ID: 9382586 [TBL] [Abstract][Full Text] [Related]
52. [A case of pulmonary metastases of breast cancer responding remarkably to combined chemotherapy with 5-fluorouracil and low-dose cisplatin]. Iwamoto M; Niiya F; Ikeda S; Nagata S; Odou E; Hayabuchi N Gan To Kagaku Ryoho; 2000 Dec; 27(14):2239-42. PubMed ID: 11142169 [TBL] [Abstract][Full Text] [Related]
53. [Neoadjuvant chemotherapy (M-VAC) in invasive cancer of the bladder. Our experience]. González Enguita C; Caro Cebrián C; Roncalés Badal A; Gil Sanz MJ; Martínez Bengoechea J; Rioja Sanz LA Arch Esp Urol; 1990; 43 Suppl 2():197-204. PubMed ID: 2096779 [TBL] [Abstract][Full Text] [Related]
54. [Relationship between tissue concentrations of 5-FU and degeneration of tissues after UFT administration in patients with bladder tumor]. Takeyama M; Honjoh M; Ohnishi N; Ishikawa Y; Sakaguchi H; Hanai J Gan To Kagaku Ryoho; 1993 Oct; 20(13):1953-9. PubMed ID: 8215468 [TBL] [Abstract][Full Text] [Related]
55. [A case in which palatal squamous cell carcinoma responded to UFT therapy]. Matsumoto T; Teramura C; Iida S; Tanaka A; Ashida H; Kimura J Gan To Kagaku Ryoho; 1999 Mar; 26(4):523-5. PubMed ID: 10097750 [TBL] [Abstract][Full Text] [Related]
56. [A case of bilateral multiple lung metastases from breast cancer successfully treated with carboplatin]. Kinoshita S; Yoshida Y; Matsuda R; Takatsuki H; Shimahara Y; Kobayashi N Gan To Kagaku Ryoho; 1995 Mar; 22(4):557-60. PubMed ID: 7887649 [TBL] [Abstract][Full Text] [Related]
57. Adjuvant therapy with 5-fluoro-1-(2-tetrahydrofuryl)-2,4 (1H,3H)-pyrimidinedione (UFT) and Bestatin in patients with transitional cell carcinoma of the bladder--comparison between UFT therapy alone and UFT therapy in combination with Bestatin. Uchibayashi T; Kunimi K; Yamamoto H; Koshida K Int J Clin Pharmacol Ther; 1995 Aug; 33(8):465-8. PubMed ID: 8556228 [TBL] [Abstract][Full Text] [Related]
58. [Effective cases of advanced endometrial and recurrent ovarian cancers treated with oral administration of UFT]. Akiyama J; Sagara Y; Takeda Y Gan To Kagaku Ryoho; 1984 Mar; 11(3):521-6. PubMed ID: 6422860 [TBL] [Abstract][Full Text] [Related]
59. Methotrexate, vinblastine, adriamycin and cisplatin (MVAC) chemotherapy for the treatment of advanced bladder carcinoma. Balbay MD; Ozen H; Uluçay S; Sahin A; Ergen A; Koçal C; Remzi D Int Urol Nephrol; 1993; 25(4):351-7. PubMed ID: 8276565 [TBL] [Abstract][Full Text] [Related]
60. [A case of lung metastases after surgery for colon cancer demonstrating complete response for more than six years after treatment with UFT/LV]. Sakamoto Y; Murata A; Koyama M; Morohashi H; Tsutsumi S; Yonaiyama S; Morita T; Hakamada K Gan To Kagaku Ryoho; 2011 Nov; 38(12):2520-2. PubMed ID: 22202433 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]